Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Hip Replacement Market Size & Growth Forecast 2027–2036, By Segments (Inserts, Product, Material, Fixation Material, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 5288| Published Date: Jul-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Hip Replacement Market size was worth USD 8.43 Billion in 2026 and is expected to grow at 4.21% CAGR between 2027 and 2036, crossing USD 12.73 Billion by 2036. The industry revenue for 2027 is assessed at USD 8.73 Billion.

Base Year Value (2025)
USD 7.7 Billion
CAGR (2026-2035)
3.7%
Forecast Year Value (2035)
USD 11.07 Billion
Historical Data Period
2021-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Hip Replacement Market Intelligence Snapshot

Regional Market Dynamics

  • North America held 52.12% in 2026, supported by advanced orthopedic infrastructure, specialized surgical expertise, sophisticated implants, rehabilitation networks, and favorable healthcare access.
  • Asia Pacific is the fastest-growing region, driven by improving healthcare infrastructure, hospital modernization, aging populations, rising orthopedic awareness, and greater adoption of advanced implants.

Segment Momentum

  • Primary hip replacement devices accounted for the largest share of 70.46% in 2026, supported by high volumes of first-time procedures that restore joint function, relieve pain, and improve patient quality of life.
  • The ceramic-on-plastic segment is expanding rapidly as healthcare providers increasingly seek bearing surfaces that reduce wear and improve long-term implant performance through advances in ceramic material technology.

Market Expansion Drivers

  • Rising prevalence of osteoarthritis and osteoporosis driving global hip replacement procedure volumes
  • Increasing trauma-related injuries boosting demand for orthopedic reconstruction surgeries
  • Growing demand for personalized and minimally invasive implant technologies improving patient outcomes

Leading Market Participants

  • Key players in the hip replacement market include Zimmer Biomet Holdings, Inc. (USA), Stryker Corporation (USA), Johnson & Johnson (DePuy Synthes) (USA), Medacta Group SA (Switzerland), MicroPort Scientific Corporation (China), Corin Group plc (UK), Enovis Corporation (USA), Kyocera Corporation (Japan), Exactech, Inc. (USA), B. Braun Melsungen AG (Germany)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 8.43 Billion
  • 2027 Estimated Market Size: USD 8.73 Billion
  • Projected Market Size: USD 12.73 Billion by 2036
  • Growth Forecast: 4.21% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Cross-linked Polyethylene Inserts (Inserts) | Primary Hip Replacement Devices (Product) | Metal-on-plastic (Material) | Cementless Fixation (Fixation Material) | Hospitals (End-use)
  • Emerging Opportunity Segment: Antioxidant Polyethylene Inserts (Inserts) | Hip Resurfacing Devices (Product) | Ceramic-on-plastic (Material) | Cementless Fixation (Fixation Material) | Ambulatory Surgical Centers (End-use)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of osteoarthritis and osteoporosis driving global hip replacement procedure volumes

The increasing burden of degenerative musculoskeletal disorders is a primary factor supporting the hip replacement market, as osteoarthritis and osteoporosis continue to reduce joint function, mobility, and quality of life among aging populations. Progressive cartilage deterioration, bone fragility, and chronic pain often limit the effectiveness of conservative treatment approaches, leading patients to seek surgical intervention for long-term symptom relief. Healthcare providers are therefore performing a greater number of hip replacement procedures to restore mobility, alleviate pain, and improve functional outcomes for individuals experiencing advanced joint degeneration associated with age-related orthopedic conditions.

Increasing trauma-related injuries boosting demand for orthopedic reconstruction surgeries

A growing incidence of trauma-related injuries will drive the hip replacement market growth by increasing the need for orthopedic reconstruction procedures following fractures and severe joint damage. Road traffic accidents, sports injuries, workplace incidents, and falls frequently result in complex hip fractures that require surgical reconstruction to restore structural stability and patient mobility. The demand is particularly pronounced among older adults, where reduced bone density can complicate fracture management and make joint replacement a preferred treatment option for achieving durable functional recovery and minimizing long-term disability.

Growing demand for personalized and minimally invasive implant technologies improving patient outcomes

The hip replacement market growth is supported by increasing demand for personalized implant solutions and minimally invasive surgical techniques that enhance procedural precision and postoperative recovery. Advances in implant design, patient-specific planning, and surgical instrumentation enable orthopedic surgeons to optimize implant positioning while preserving healthy tissue and reducing surgical trauma. These innovations contribute to improved joint function, greater implant compatibility, shorter rehabilitation periods, and enhanced patient satisfaction, encouraging broader acceptance of hip replacement procedures among both patients and healthcare providers.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of osteoarthritis and osteoporosis driving global hip replacement procedure volumes 2% High North America, Europe High Near Term
Increasing trauma-related injuries boosting demand for orthopedic reconstruction surgeries 1.6% High Asia Pacific, Latin America High Mid Term
Growing demand for personalized and minimally invasive implant technologies improving patient outcomes 1.4% High Europe, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
52.12% Market Share in 2026

North America (Largest Region)

In the hip replacement market, North America accounted for the largest share of 52.12% in 2026, driven by advanced orthopedic healthcare infrastructure, high availability of specialized surgical expertise, and widespread access to sophisticated joint replacement procedures. The region benefits from strong adoption of advanced implant technologies, established rehabilitation networks, and growing demand for surgical interventions that improve mobility and quality of life. An aging population and increasing prevalence of musculoskeletal conditions are also sustaining procedure volumes, while favorable healthcare access supports continued adoption of hip replacement solutions.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is emerging as the fastest-growing region, supported by improving healthcare infrastructure, expanding access to orthopedic services, and rising awareness of joint replacement procedures. Population aging, increasing incidence of degenerative joint conditions, and improvements in surgical capabilities are encouraging more patients to seek effective mobility-restoring treatments. Healthcare investments and the modernization of hospitals are further expanding access to orthopedic surgery, while growing medical expertise and adoption of advanced implant technologies are creating favorable conditions for continued market development.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Advanced Orthopedic Adoption

The U.S. hip replacement market is supported by broad adoption of advanced implants, robotic-assisted procedures, and outpatient surgical models. Healthcare providers in the U.S. continue emphasizing improved clinical outcomes, implant longevity, and patient recovery efficiency.

Germany 🇩🇪

Precision Implant Utilization

Germany emphasizes high-quality orthopedic implants supported by advanced surgical techniques and specialized clinical expertise. Hospitals in Germany continue investing in precision procedures and evidence-based treatment pathways that improve long-term patient outcomes.

Japan 🇯🇵

Aging Care Solutions

Japan prioritizes hip replacement procedures that address mobility needs associated with an aging population. Healthcare providers in Japan focus on minimally invasive surgical approaches, durable implant technologies, and rehabilitation strategies that support faster functional recovery.

South Korea 🇰🇷

Digital Surgery Integration

South Korea increasingly integrates digital planning tools, navigation systems, and advanced orthopedic implants into hip replacement procedures. Medical institutions in South Korea emphasize surgical precision, efficient recovery protocols, and continuous orthopedic technology adoption.

France 🇫🇷

Patient-Centered Orthopedics

France supports hip replacement through established orthopedic care pathways focused on patient safety and long-term mobility improvement. Healthcare providers in France prioritize clinically validated implant systems and coordinated rehabilitation to enhance treatment effectiveness.

Italy 🇮🇹

Specialized Surgical Expertise

Italy maintains steady demand for hip replacement procedures through experienced orthopedic centers and expanding access to modern implant technologies. Hospitals in Italy focus on surgical quality, postoperative rehabilitation, and optimized care pathways to improve patient mobility.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Hip Replacement Market Share (%), Inserts, 2025

Cross-linked Polyethylene Inserts
Antioxidant Polyethylene Inserts
Non-antioxidant Polyethylene Inserts

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Inserts Segment Analysis: Cross-linked Polyethylene Inserts (Largest Segment) vs Antioxidant Polyethylene Inserts (Fastest-Growing Segment)

The cross-linked polyethylene inserts segment held the largest share of the hip replacement market in 2026 due to its superior wear resistance and long-term durability in joint replacement procedures. These inserts are widely adopted because they help reduce implant wear, support implant longevity, and improve overall clinical performance, making them a preferred choice for orthopedic surgeons treating a broad patient population. Continued advancements in implant design and increasing emphasis on durable orthopedic solutions further reinforce the segment's leadership.

Antioxidant polyethylene inserts are anticipated to witness the fastest growth as healthcare providers increasingly seek implant materials with enhanced resistance to oxidative degradation and improved long-term performance. Ongoing innovation in biomaterials and growing demand for implants designed to maximize durability and patient outcomes are encouraging broader adoption of antioxidant-enhanced polyethylene technologies.

Product Segment Analysis: Primary Hip Replacement Devices (Largest Segment) vs Hip Resurfacing Devices (Fastest-Growing Segment)

The primary hip replacement devices segment dominated the hip replacement market with a 70.46% share in 2026, driven by the high volume of first-time hip replacement procedures performed to manage degenerative joint diseases and age-related mobility disorders. These devices are extensively utilized because they provide effective pain relief, restore joint function, and support long-term improvements in patient quality of life. Expanding access to orthopedic care and ongoing advances in surgical techniques continue to sustain demand for primary hip replacement procedures.

Hip resurfacing devices are expected to experience the fastest growth as orthopedic specialists increasingly consider bone-conserving treatment approaches for appropriately selected patients. Their ability to preserve more natural bone structure while maintaining joint function makes them an attractive option, particularly for active individuals seeking alternatives to conventional total hip replacement procedures.

Material Segment Analysis: Metal-on-plastic (Largest Segment) vs Ceramic-on-plastic (Fastest-Growing Segment)

Holding the largest share of the hip replacement market, the metal-on-plastic segment accounted for 59.78% in 2026 because it offers a well-established combination of clinical reliability, durability, and cost-effectiveness. The material pairing has been extensively adopted across orthopedic procedures due to its consistent performance, broad surgeon familiarity, and suitability for a wide range of patient profiles. Continued improvements in polyethylene technology further support its widespread clinical use.

The ceramic-on-plastic segment is projected to grow the fastest as healthcare providers increasingly adopt bearing surfaces designed to reduce wear while enhancing long-term implant performance. Improvements in ceramic material technology, combined with increasing demand for durable implants that support favorable patient outcomes, are contributing to expanding adoption of ceramic-on-plastic hip replacement systems.

Segment Sub-Segment Largest Segment Fastest Growing
Inserts Cross-linked Polyethylene Inserts, Antioxidant Polyethylene Inserts, Non-antioxidant Polyethylene Inserts Cross-linked Polyethylene Inserts Antioxidant Polyethylene Inserts
Product Primary Hip Replacement Devices, Partial Hip Replacement Devices, Revision Hip Replacement Devices, Hip Resurfacing Devices Primary Hip Replacement Devices Hip Resurfacing Devices
Material Metal-on-plastic, Ceramic-on-plastic, Ceramic-on-ceramic, Others Metal-on-plastic Ceramic-on-plastic
Fixation Material Cemented Fixation, Cementless Fixation, Hybrid Fixation Cementless Fixation Cementless Fixation
End-use Hospitals, Ambulatory Surgical Centers Hospitals Ambulatory Surgical Centers
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the hip replacement market:

  1. Zimmer Biomet Holdings, Inc. (USA)
  2. Stryker Corporation (USA)
  3. Johnson & Johnson (DePuy Synthes) (USA)
  4. Medacta Group SA (Switzerland)
  5. MicroPort Scientific Corporation (China)
  6. Corin Group plc (UK)
  7. Enovis Corporation (USA)
  8. Kyocera Corporation (Japan)
  9. Exactech, Inc. (USA)
  10. B. Braun Melsungen AG (Germany)

Innovation in implant performance is steadily redefining competitive positioning within the hip replacement market, where manufacturers are advancing implant materials, fixation techniques, and anatomical designs to improve long-term clinical outcomes across diverse patient populations. The focus has expanded beyond individual implants toward integrated procedural solutions that combine surgical planning, precision instrumentation, and digital technologies to support greater consistency during implantation. At the same time, providers capable of generating strong clinical confidence through surgeon education, procedural support, and comprehensive product portfolios are strengthening their presence as healthcare systems increasingly prioritize efficiency alongside durable patient outcomes.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Kinomatic Jun-26 Kinomatic secured $4 million in a seed funding round led by Waterline Ventures. The capital injection will scale the company's orthopedic technology platform, accelerating growth and expanding its competitive position within the joint replacement ecosystem.
Stryker Apr-26 Stryker introduced the Trident II Acetabular System to the Indian market, expanding its local orthopedic footprint. The commercial launch delivers advanced implant technology to regional surgeons, accelerating competitive positioning within India's growing hip replacement segment.
Zimmer Biomet Jul-25 Zimmer Biomet agreed to acquire Monogram for $177 million to expand its autonomous and robotic-assisted portfolio. The transaction enhances the company's capabilities in robotic surgery platforms specifically designed for orthopedic and joint replacement applications.
Garland Surgical Mar-25 Garland Surgical secured up to €1.4 million in grant funding from Malta Enterprise. The non-dilutive capital supports operational scaling and structural innovation in orthopedic medical technologies, focusing on advanced solutions for joint replacement surgery.
Stryker Jan-25 Stryker launched the Insignia Hip Stem in India for total hip replacement and hemiarthroplasty. The commercial rollout expands the company's structural implant portfolio and strengthens its market share in the country's orthopedic care sector.
Zimmer Biomet Sep-24 Zimmer Biomet initiated a product recall for its discontinued CPT hip replacement implant, which the FDA subsequently elevated. The regulatory escalation follows a identified risk association with postoperative femur fractures, carrying operational and legal risk implications for the company's historical portfolio.
Zimmer Biomet Aug-24 Zimmer Biomet acquired OrthoGrid Systems, integrating the Hip AI fluoroscopy-based surgical guidance platform into its ecosystem. The transaction strengthens the company's AI-enabled digital health portfolio, optimizing surgical planning and intraoperative navigation for hip arthroplasty procedures.
Stryker Feb-24 Stryker rolled out software and system updates to its Mako SmartRobotics platform, introducing advanced joint replacement capabilities. The technological integration enhances robotic-assisted workflows, improving precision and clinical execution during complex hip replacement procedures.
Exactech Aug-22 Exactech completed the commercial launch of its innovative Total Hip Arthroplasty System. The system integrates advanced materials and structural engineering to drive surgical precision, promote implant customization, and optimize clinical outcomes during hip replacement surgeries.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Hip Replacement Market — Custom Segments

Segment Sub-Segment
No segment data available.

Hip Replacement Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the hip replacement market?

In 2027 the market for hip replacement is valued at USD 8.73 Billion.

What are the growth projections for the hip replacement industry?

Hip Replacement Market size was worth USD 8.43 Billion in 2026 and is expected to grow at 4.21% CAGR between 2027 and 2036, crossing USD 12.73 Billion by 2036.

How are advances in implant technologies influencing the hip replacement market?

Personalized implants and minimally invasive surgical techniques are improving implant positioning, reducing tissue disruption, and supporting faster recovery. These advancements enhance patient outcomes and encourage wider adoption of hip replacement procedures.

How are changing patient demographics driving demand for hip replacement procedures?

Increasing cases of osteoarthritis, osteoporosis, and trauma-related injuries are raising procedure volumes as healthcare providers perform more hip replacements to restore mobility, relieve pain, and improve long-term functional outcomes.

Which product segment dominates the hip replacement market?

Primary hip replacement devices accounted for the largest share of 70.46% in 2026, supported by high volumes of first-time procedures that restore joint function, relieve pain, and improve patient quality of life.

Why is the ceramic-on-plastic material segment growing the fastest?

The ceramic-on-plastic segment is expanding rapidly as healthcare providers increasingly seek bearing surfaces that reduce wear and improve long-term implant performance through advances in ceramic material technology.

What supports North America's leadership in the hip replacement market?

North America held 52.12% in 2026, supported by advanced orthopedic infrastructure, specialized surgical expertise, sophisticated implants, rehabilitation networks, and favorable healthcare access.

How is Asia Pacific creating growth opportunities in hip replacement?

Asia Pacific is the fastest-growing region, driven by improving healthcare infrastructure, hospital modernization, aging populations, rising orthopedic awareness, and greater adoption of advanced implants.

Which companies are driving growth in the hip replacement landscape?

Key players in the hip replacement market include Zimmer Biomet Holdings, Inc. (USA), Stryker Corporation (USA), Johnson & Johnson (DePuy Synthes) (USA), Medacta Group SA (Switzerland), MicroPort Scientific Corporation (China), Corin Group plc (UK), Enovis Corporation (USA), Kyocera Corporation (Japan), Exactech, Inc. (USA), B. Braun Melsungen AG (Germany)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →